Thermostable tag (TST) protein expression system: Engineering thermotolerant recombinant proteins and vaccines

Journal of Biotechnology

Volumn 151, Issue 3, 2011, Pages 242-250

  Luke, Jeremy M ^a   Carnes, Aaron E ^a   Sun, Ping ^b   Hodgson, Clague P ^a   Waugh, David S ^b   Williams, James A ^a  

^a NATURE TECHNOLOGY CORPORATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Affinity tag; Flagellin; Hemagglutinin; Maltodextrin binding protein; Thermostable; Vaccine

Indexed keywords

AFFINITY TAG; FLAGELLIN; HEMAGGLUTININ; MALTODEXTRINS; THERMOSTABLE;

BIOCHEMICAL ENGINEERING; FERMENTATION; GENETIC ENGINEERING; MANUFACTURE; VACCINES;

PROTEINS;

ANTIGEN; FLAGELLIN; HN FLAGELLIN VACCINE; HN PFMBP FLAGELLIN VACCINE; HYBRID PROTEIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; EXPRESSION VECTOR; HEAT TOLERANCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PYROCOCCUS FURIOSUS; THERMOSTABILITY; VACCINE PRODUCTION;

AFFINITY LABELS; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; CARRIER PROTEINS; CIRCULAR DICHROISM; CLONING, MOLECULAR; FERMENTATION; FLAGELLIN; GENETIC VECTORS; HEK293 CELLS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; PROTEIN ENGINEERING; PROTEIN STABILITY; RECOMBINANT FUSION PROTEINS; TEMPERATURE;

PYROCOCCUS FURIOSUS;

EID: 79151484525     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2010.12.011     Document Type: Article

References (32)

1. Burdelya L.G., Krivokrysenko V.I., Tallant T.C., Strom E., Gleiberman A.S., Gupta D., Kurnasov O.V., Fort F.L., Osterman A.L., Didonato J.A., Feinstein E., Gudkov A.V. An agonist of Toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008, 320:226-230.
2. Chen D., Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev. Vaccines 2009, 8:547-557.
3. Chiu F.F., Venkatesan N., Wu C.R., Chou A.H., Chen H.W., Lian S.P., Liu S.J., Huang C.C., Lian W.C., Chong P., Leng C.H. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochem. Biophys. Res. Commun. 2009, 383:27-31.
4. de Marco A., Casatta E., Savaresi S., Geerlof A. Recombinant proteins fused to thermostable partners can be purified by heat incubation. J. Biotechnol. 2004, 107:125-133.
5. Fernandez S., Palmer D.R., Simmons M., Sun P., Bisbing J., McClain S., Mani S., Burgess T., Gunther V., Sun W. Potential role for Toll-like receptor 4 in mediating Escherichia coli maltose-binding protein activation of dendritic cells. Infect. Immun. 2007, 75:1359-1363.
6. Fox J.D., Routzahn K.M., Bucher M.H., Waugh D.S. Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers. FEBS Lett. 2003, 537:53-57.
7. Fox J.D., Waugh D.S. Maltose-binding protein as a solubility enhancer. Methods Mol. Biol. 2003, 205:99-117.
8. Gerdts V., Mutwiri G.K., Tikoo S.K., Babiuk L.A. Mucosal delivery of vaccines in domestic animals. Vet. Res. 2006, 37:487-510.
9. Honko A.N., Mizel S.B. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect. Immun. 2004, 72:6676-6679.
10. Honko A.N., Sriranganathan N., Lees C.J., Mizel S.B. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect. Immun. 2006, 74:1113-1120.
11. Huang H., Liu J., de Marco A. Induced fit of passenger proteins fused to Archaea maltose binding proteins. Biochem. Biophys. Res. Commun. 2006, 344:25-29.
12. Huleatt J.W., Jacobs A.R., Tang J., Desai P., Kipp E.B., Huang Y., Song L., Nakaar V., Powell T.J. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 2007, 25:763-775.
13. Kink J.A., Williams J.A. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect. Immun. 1998, 66:2018-2025.
14. Lahira A., Das P., Chakravortty D. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine 2008, 26:6777-6783.
15. Lightfield K.L., Persson J., Brubaker S.W., Witte C.E., von Moltke J., Dunipace E.A., Henry T., Sun Y.H., Cado D., Dietrich W.F., Monack D.M., Tsolis R.M., Vance R.E. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 2008, 9:1171-1178.
16. Mizel S.B., Graff A.H., Siranganathan N., Ervin S., Lees C.J., Lively M.O., Hantgan R.R., Thomas M.J., Wood J., Bell B. A fusion protein, flagellin/F1/V, is an effective plague vaccine in mice and two species of nonhuman primates. Clin. Vaccine Immunol. 2009, 16:21-28.
17. Mossman K.L., Mian M.F., Lauzon N.M., Gyles C.L., Lichty B., Mackenzie R., Gill N., Ashkar A.A. Cutting edge: FimH adhesion of type 1 fimbriae is a novel TLR4 ligand. J. Immunol. 2008, 181:6702-6706.
18. Murthy K.G.K., Deb A., Goonesekera S., Szabo C., Salzman A.L. Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J. Biol. Chem. 2004, 279:5667-5675.
19. Parsell D.A., Silber K.R., Sauer R.T. Carboxy-terminal determinants of intracellular protein degradation. Genes Dev. 1990, 4:277-286.
20. Ramos H.C., Rumbo M., Sirard J.C. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12:509-517.
21. Rebl A., Goldammer T., Seyfert H.M. Toll-like receptor signaling in bony fish. Vet. Immunol. Immunopathol. 2010, 134:139-150.
22. Ren X., Yu D., Yu L., Gao G., Han S., Feng Y. A new study of cell disruption to release recombinant thermostable enzyme from Escherichia coli by thermolysis. J. Biotechnol. 2007, 129:668-673.
23. Singleton T.E., Massari P., Wetzler L.M. Neisserial porin-induced dendritic cell activation is myd88 and TLR2 dependent. J. Immunol. 2005, 174:3545-3550.
24. Skountzou I., Martin M.D., Wang B., Ye L., Koutsonanos D., Weldon W., Jacob J., Compans R.W. Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. Vaccine 2010, 28:4103-4112.
25. Song L., Nakaar V., Kavita U., Price A., Huleatt J., Tang J., Jacobs A., Liu G., Huang Y., Desai P., Maksymiuk G., Takahashi V., Umlauf S., Reiserova L., Bell R., Li H., Zhang Y., McDonald W.F., Powell T.J., Tussey L. Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs. PLoS ONE 2008, 3:e2257.
26. Sørensen H.P., Mortensen K.K. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 2005, 115:113-128.
27. Trepod C.M., Mott J.E. Modification of the carboxy-terminal amino acid sequence alters the Escherichia coli expression of a gene encoding multiple repeats of a bovine growth hormone releasing factor analog. J. Biotechnol. 2000, 84:273-284.
28. Vijay-Kumar M., Aitken J.D., Sanders C.J., Frias A., Sloane V.M., Xu J., Neish A.S., Rojas M., Gewirtz A.T. Flagellin treatment protects against chemicals, bacteria, viruses and radiation. J. Immunol. 2008, 180:8280-8285.
29. Williams J.A., Langeland J.A., Thalley B., Skeath J.B., Carroll S.B. Production and purification of polyclonal antibodies against proteins expressed in E. coli. DNA Cloning: Expression Systems 1994, IRL Press.
30. Xu Y., Foong F.C. Characterization of a cellulose binding domain from Clostridium cellulovorans endoglucanase-zylanase D and its use as a fusion partner for soluble protein expression in Escherichia coli. J. Biotechnol. 2008, 135:319-325.
31. Zimmerman T., Frère C.P., Satzger M., Raba M., Weisbach M., Döhn K., Popp A., Donzeau M. Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments. J. Immunol. Methods 2006, 314:67-73.
32. Zou Z., Cao L., Zhou P., Su Y., Sun Y., Li W. Hyper-acidic protein fusion partners improve solubility and assist correct folding of recombinant proteins expressed in Escherichia coli. J. Biotechnol. 2008, 135:333-339.